Use App
Trending
News
Earnings
All
DIA
0.08%
SPY
0.17%
QQQ
1.57%
Trending
NBIS
16.32%
CRWV
13.08%
META
8.82%
JACK
11.76%
IREN
5.10%
SOUN
3.55%
ONDS
3.76%
GLW
13.28%
HIMS
7.73%
CLSK
6.32%
NBIS
16.32%
CRWV
13.08%
META
8.82%
JACK
11.76%
IREN
5.10%
SOUN
3.55%
ONDS
3.76%
GLW
13.28%
HIMS
7.73%
CLSK
6.32%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
ENTA
Exchange:
NASDAQ
·
Updated 04:10 PM EDT
ENTA
Enanta Pharmaceuticals Inc
$14.77
$0.19
(1.30%)
Today
·
Closed $14.77
$0.00
(0.00%)
After Hours
1
,
1
5
0
1
,
1
5
0
Earnings
Aug 10
Mkt Cap
$423.96M
Vol
206,504.00
Full Chart
Fundamentals
Mkt Cap
$423.96M
Volume
-
52W High
$17.15
52W Low
$6.44
PE Ratio
-5.62
Avg. Volume
226,214.56
EPS (Annual)
-$3.84
P/B
3.63
Rev/Employee
$544,366.67
Earnings
Aug 10
Advertisement
|
Remove ads.
Latest ENTA News
View
Enanta Pharmaceuticals (ENTA) Moves 5.2% Higher: Will This Strength Last?
Zacks
Enanta Pharmaceuticals Partner AbbVie Receives European Commission Approval of MAVIRET (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
Business Wire
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)
Business Wire
Loading...
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile